한글목차

세계 광선각화증 시장은 2025년에 91억 8,000만 달러, 2032년에는 130억 1,000만 달러에 달할 것으로 예상되며, 2025년부터 2032년까지 연평균 5.1%의 성장률을 보일 것으로 예상됩니다.

그림. 2025년 지역별 광선각화증 시장 점유율(%)

광선각화증은 태양의 자외선에 장기간 노출되어 발생하는 전암성 피부질환입니다. 얼굴, 입술, 귀, 대머리 두피, 팔뚝, 손등, 아랫입술 등 햇빛에 노출된 부위에 생기는 비늘이나 딱지 같은 반점이 특징입니다. 이러한 반점은 표피의 상층부에 있는 각질세포의 비정상적이고 통제할 수 없는 증식으로 인해 발생합니다. 방치하면 피부암의 일종인 편평상피암으로 발전할 수 있습니다. 피부 건강과 조기 진단에 대한 인식이 높아짐에 따라 전 세계 광선각화증 시장의 성장을 주도하고 있습니다.

시장 역학

세계 광선각화증 시장은 주로 햇볕에 의한 유병률 증가에 의해 주도되고 있습니다. 장시간 무방비 상태로 자외선에 노출되는 것은 광선각화증의 주요 위험 요인입니다. 야외 레크리에이션 활동과 직업적 자외선 노출이 증가함에 따라 효과적인 치료 및 관리 옵션에 대한 수요가 꾸준히 증가하고 있습니다. 또한, 치료법에 대한 유리한 상환 정책과 새로운 치료법의 승인 증가도 시장 성장에 박차를 가하고 있습니다. 그러나 브랜드 의약품의 높은 가격은 여전히 중요한 과제입니다. 더 나은 효능과 치료 기간을 단축하는 새로운 제형에 대한 지속적인 연구는 이 문제를 극복하고 세계 광선각화증 시장에 더 많은 성장 기회를 제공할 수 있습니다.

본 조사의 주요 특징

• 세계의 광선각화증 시장을 상세하게 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 동안 시장 규모(10억 달러)와 연평균 성장률(CAGR)을 조사하여 전해드립니다.
• 또한, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰을 제공합니다.
• 세계 광선각화증 시장의 주요 기업들을 기업 소개, 제품 포트폴리오, 주요 특징, 주요 성과, 전략 등의 매개 변수를 기반으로 프로파일링합니다.
• 주요 기업으로는 Almirall, S.A., Bausch Health Companies Inc. Pharmaceuticals, Inc., Bioforntera AG, Cipher Pharmaceuticals Inc., Vidac, Athenex, Inc. 등이 있습니다.
• 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대, 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
• 세계 광선각화증 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
• 이해관계자들은 세계 광선각화증 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.

목차

제1장 조사 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 인수와 제휴 시나리오
• 제품 발매/승인
• 브랜드와 가격 분석
• 자금조달과 투자
• PEST 분석
• Porter의 Five Forces 분석

제4장 세계의 광선각화증 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부 이니셔티브
• 시장에 대한 COVID-19의 영향

제5장 세계의 광선각화증 시장, 치료 유형별, 2020년-2032년(10억 달러)

• 국소 치료
• 수술 시술
• 광선 역학 요법
• 기타

제6장 세계의 광선각화증 시장, 최종사용자별, 2020년-2032년(10억 달러)

• 병원
• 피부과 클리닉
• 스파 및 회춘 센터
• 가정치료 환경
• 기타

제7장 세계의 광선각화증 시장, 지역별, 2020년-2032년(10억 달러)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제8장 경쟁 구도

• 기업 개요
  • Almirall, SA
  • Bausch Health Companies Inc.
  • Perrigo Company plc.
  • Sun Pharmaceutical Industries Ltd.
  • Hill Dermaceuticals, Inc.
  • Tolmar Pharmaceuticals, Inc.
  • Bioforntera AG
  • Cipher Pharmaceuticals Inc.
  • Vidac
  • Athenex, Inc.
  • GALDERMA
  • LEO Pharma A/S

제9장 애널리스트의 견해

• 기회
• 애널리스트의 견해
• Coherent Opportunity Map

제10장 참고 문헌과 조사 방법

• 참고 문헌
• 조사 방법

영문목차

Global Actinic Keratosis Market is estimated to be valued at USD 9.18 Bn in 2025 and is expected to reach USD 13.01 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

Figure. Actinic Keratosis Market Share (%), By Region 2025

Actinic keratosis is a precancerous skin condition caused by prolonged exposure to UV radiation from the sun. It is characterized by scaly or crusty patches that develop on sun-exposed areas like the face, lips, ears, bald scalp, forearms, the back of the hands, and lower lips. These patches are caused by the abnormal and uncontrolled growth of keratinocytes in the upper layer of the epidermis. If left untreated, actinic keratosis has the potential to develop into squamous cell carcinoma, a type of skin cancer. Rising awareness regarding skin health and early diagnosis has been driving the global actinic keratosis market growth.

Market Dynamics:

The global actinic keratosis market is primarily driven by the increasing prevalence of the condition owing to sun exposure. Prolonged and unprotected exposure to ultraviolet radiation is the main risk factor for actinic keratosis. With rising outdoor recreational activities and occupational sun exposure, the demand for effective treatment and management options is steadily increasing. Additionally, favorable reimbursement policies for treatment procedures and increasing approval of new treatment modalities are providing impetus to the market growth. However, high cost of branded drugs remains a key challenge. Ongoing research into new formulations with better efficacy and reduced treatment duration can help overcome this challenge and further create growth opportunities in the global actinic keratosis market.

Key Features of the Study:

• This report provides an in-depth analysis of the global actinic keratosis market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global actinic keratosis market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes Almirall, S.A, Bausch Health Companies Inc., Perrigo Company plc., Sun Pharmaceutical Industries Ltd., Hill Dermaceuticals, Inc., Tolmar Pharmaceuticals, Inc., Bioforntera AG, Cipher Pharmaceuticals Inc., Vidac, Athenex, Inc., GALDERMA, and LEO Pharma A/S.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global actinic keratosis market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global actinic keratosis market.

Detailed Segmentation-

• By Treatment Type:
  • Topical Treatment
  • Surgical Procedure
  • Chemical peels
  • Cryosurgery
  • Curettage and desiccation
  • Others
  • Photodynamic Therapy
  • Others
• By End User:
  • Hospitals
  • Dermatology Clinics
  • Spas and Rejuvenation Centers
  • Homecare Settings
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Almirall, S.A
  • Bausch Health Companies Inc.
  • Perrigo Company plc.
  • Sun Pharmaceutical Industries Ltd.
  • Hill Dermaceuticals, Inc.
  • Tolmar Pharmaceuticals, Inc.
  • Bioforntera AG
  • Cipher Pharmaceuticals Inc.
  • Vidac
  • Athenex, Inc.
  • GALDERMA
  • LEO Pharma A/S

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Treatment Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Brand and Pricing Analysis
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Actinic Keratosis Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Actinic Keratosis Market, By Treatment Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Topical Treatment
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Surgical Procedure
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Chemical peels
  • Cryosurgery
  • Curettage and desiccation
  • Others
• Photodynamic Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Actinic Keratosis Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Dermatology Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Spas and Rejuvenation Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Homecare Settings
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Actinic Keratosis Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

• Company Profiles
  • Almirall, S.A
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Bausch Health Companies Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Perrigo Company plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Sun Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Hill Dermaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Tolmar Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Bioforntera AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Cipher Pharmaceuticals Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Vidac
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • Athenex, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • GALDERMA
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
  • LEO Pharma A/S
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

9. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

10. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact

"